In the article, "Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow," by Maegen A. Ackermann, Puja D. Patel, Jane Valenti, Yasuharu Tagaki, Earl Homsher, James R. Sellers, and Aikaterini Kontrogianni-Konstantopoulos, in *FASEB J*. August 2013 27:3217--3228 (doi: 10.1096/fj.13-228882), there are errors in the "Input Protein" included in Figs. 4*A*, *D* and 5*A*, *B*. These errors do not change the results shown in Figs. 4 and 5 or the conclusions drawn from the study.

The corrected images and legends are as follows:

![Alternative splicing within the C7 domain has no effect on actomyosin interactions; however, alternative splicing within the C10 domain affects its ability to interact with thick filaments. *A*, *D*) C7 (*A*) and C10 (*D*) domain constructs of sMyBP-C (C7~aa720--823~ and C7Δ763--780^aa720--823^, *A*; and C10~aa1016--1127~ and C10Δ1107--1127~aa1016--1127~, *D*) were assessed for their ability to interact with endogenous myosin and actin in GST pulldown assays. *E*, *F*) Far-Western blot (*E*) and slot blot (*F*) assays were also performed with the C10 domain constructs (C10~aa1016--1127~ and C10Δ1107--1127~aa1016--1127~) to assay for direct interactions with actin and HMM. Although the COOH terminus of sMyBP-C is complexed with myosin and actin filaments in a variant-specific manner (*D*), it is not able to directly interact with HMM or actin (*B*). *B*, *C*, *G*, *H*) *In vitro* motility assays were used to measure the sliding velocity of actin filaments over a surface coated with HMM in the presence or absence of the C7 (C7~aa720--823~ and C7Δ763--780~aa720--823~; *B*, *C*) and C10 (C10~aa1016--1127~ and C10Δ1107--1127~aa1016--1127~; *G*, *H*) domain proteins. *B*, *G*) Bar graphs indicate the percentage change in the sliding velocity of actin filaments normalized to sham conditions. *C*, *H*) Bar graphs depict the percentage ± [se]{.smallcaps} of available actin at the gliding surface 75 s following addition of the sMyBP-C proteins. Insets: representative snapshots of the gliding surface 75 s following the addition of the proteins at 1 μM. \**P* \< 0.01 *vs*. sham treatment; *t* test.](fj.13-228882ERRf4){#F4}

![COOH terminus of sMyBP-C mediates binding to thick filaments but fails to support binding in the presence of the Y856H DA-1 mutation. *A*) GST pulldown assays were used to assess the ability of the extended COOH-terminal constructs of sMyBP-C (C8--C10~aa854--1127~ and C8--C10Δ1107--1127~aa854--1127~) to interact with endogenous myosin and actin. *B*) COOH-terminal constructs of sMyBP-C carrying the Y856H DA-1 mutation (C8--C10Y856H~aa854--1127~ and C8--C10Δ1107--1127 Y856H~aa854--1127~) were assessed for their ability to interact with endogenous myosin and actin. The presence of the Y856H DA-1 mutation abolishes all binding activity.](fj.13-228882ERRf5){#F5}

These errors have been corrected online. The authors regret any inconvenience caused by these errors.
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